L2M Validation / Qc Automne 2025 / Sécurisation des ordinateurs quantiques contre des cybermenaces

La concrétisation des ordinateurs quantiques introduit de nouveaux vecteurs d’attaque tels que les virus quantiques, les cyberattaques quantiques. Les outils actuels de détection des virus informatiques ou des menaces cyber n’ont pas été conçus pour les ordinateurs quantiques, les exposant ainsi à des nouvelles vulnérabilités qui peuvent être exploitées par les acteurs malicieux. Les fournisseurs […]

Read More
L2M – Modular Hybrid Air Purification System

Indoor air pollution has become a growing concern, especially in homes, schools, offices, and healthcare facilities where people spend most of their time. Existing commercial air purifiers are often limited in function, focusing on removing specific pollutants while requiring frequent manual filter replacements. Many are not compatible with HVAC systems and often produce noise and […]

Read More
L2M – Forge Climate Business Development

Cement manufacturing is responsible for approximately 8% of global CO2 emissions, equivalent to all gas-powered passenger vehicles on the road today. The primary emissions source is the high-temperature decomposition of limestone, a process deeply embedded in traditional cement production. Forge Climate is tackling this challenge with a novel, electricity-driven solution: the cement electrolyzer. Powered by […]

Read More
L2M – Antioxidant-rich Functional Fiber Developed from Co-products of Cereals and Legumes

Antioxidant dietary fiber is an emerging concept that combines the health benefits of dietary fiber and natural polyphenolic antioxidants into a single functional ingredient. Dietary fiber supports gut and heart health, blood sugar regulation, weight management, and digestive well-being. Phenolic compounds, commonly found in colorful fruits and vegetables, help protect the body from oxidative damage […]

Read More
L2M- A Strategic Commercialization Pathway for Electrochemical Antifouling Membranes

This project will support the commercialization of a new electrochemical membrane (ECM) technology that actively prevents fouling in wastewater treatment systems, offering a sustainable, low-maintenance alternative to conventional membranes. Through structured market research, stakeholder engagement, and techno-economic analysis, the project will identify high-potential market segments and build a clear commercialization roadmap. The partner organization will […]

Read More
L2M — Development and Validation of a Novel Pain-Conscious Tool for IUD and Endometrial Biopsy Procedures

This project supports the development of an innovative device that makes IUD insertions and endometrial biopsies less painful and more accurate. By replacing outdated tools with one integrated system, it improves patient comfort and clinical efficiency. The project will provide ReFem Technologies with real-world feedback, regulatory insights, and a clear path to market, accelerating the […]

Read More
L2M-Validation of solid lubricant coatings for industry applications

The proposed Lab2Market internship program will support the intern, who is currently working with AraMill, in strengthening their understanding of validation processes vital for the commercialization of innovative lubrication solutions. The organization specializes in developing advanced, sustainable metallic solid lubricant coatings for machining tools, which significantly reduce friction and eliminate the need for traditional liquid […]

Read More
L2M – Ultracoustics Development Project

Ultracoustics Technologies Ltd. is developing ultrasensitive optical microphones to detect high-frequency sounds (20 kHz–2 MHz) for industrial applications like non-destructive testing (NDT) and leak detection. While the technology is proven, the company lacks market-ready products and a clear commercialization path. This Mitacs Business Strategy Internship project will bridge that gap by: (1) finalizing a certified […]

Read More
L2M Validation / Qc Automne 2025 / Projet Inova : Une intellignance artificielle pour l’optimisation de l’utilisation des technologies d’assistance pour la navigation intérieure des personnes déficientes visuelles au Canada

Le projet Inova vise à développer une plateforme intelligente optimisant l’usage des technologies d’assistance pour la navigation intérieure des personnes déficientes visuelles (PDV) au Canada. Pendant le stage, je réaliserai une étude approfondie des besoins des utilisateurs, afin d’identifier les barrières à l’adoption des technologies assistance et d’évaluer la désirabilité, la faisabilité et la viabilité […]

Read More
L2M-WEARNOVAI: AI-ASSISTED WEARABLE MICROFLUIDIC PLATFORM FOR NON-INVASIVE DETECTION OF INFLAMMATORY BIOMARKERS IN SWEAT

WearNovAI is a smart, wearable device that can detect early signs of neurological conditions like Alzheimer’s and epilepsy by analyzing sweat. Traditional tools used to diagnose these diseases are often invasive, expensive, and difficult to access, especially in remote or underserved areas. This new wearable sensor offers a non-invasive, real-time alternative by identifying inflammation-related biomarkers […]

Read More
L2M-Smart Decontamination: continous PAH Monitoring and AI-Enhanced Safety for Firefighters

This project aims to develop a continuous monitoring system to detect cancer-causing chemicals called polycyclic aromatic hydrocarbons (PAHs) that firefighters are exposed to during their work. These harmful substances stick to their gear, skin, and even enter fire stations and vehicles, increasing long-term health risks like cancer. The project will create smart sensors using advanced […]

Read More
L2M Launch / Qc Fall 2025 / Espoir Biosciences

Ce projet vise à transformer une découverte scientifique prometteuse en une entreprise biotechnologique dédiée au développement d’un traitement innovant contre la sclérose latérale amyotrophique (SLA), une maladie neurodégénérative incurable. Issu du laboratoire du Dr Alex Parker au CRCHUM, le traitement proposé repose sur un mécanisme inédit de régénération des neurones endommagés. Les traitements actuellement disponibles […]

Read More